Ulotaront

(Synonyms: SEP-363856; SEP-856)
11 Cited Publications
고객리뷰

Based on 11 publication(s) in Google Scholar

Ulotaront (SEP-363856; SEP-856) is an orally active, blood-brain barrier-penetrant TAAR1 full agonist with an EC50 of 0.14 µM. Ulotaront is a 5-HT1A agonist and a weak agonist of 5-HT1B and 5-HT7 receptors. Ulotaront state-dependently modulates glutamatergic synaptic transmission in the striatum and hippocampus, reducing spontaneous glutamatergic synaptic activity and enhancing evoked synaptic responses. Ulotaront exhibits antipsychotic-like effects in animal models of schizophrenia and also improves glucose tolerance and reduces body weight by delaying gastric emptying and modulating central neural circuits related to energy balance. Ulotaront can be used in research on schizophrenia and obesity.

The free form of the compound is prone to instability, it is advisable to consider the stable salt form (Ulotaront hydrochloride) that retains the same biological activity.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • CAS No.: 1310426-33-5
  • 화학식: C9H13NOS
  • 분자량:183.27
  • 보관:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocol
  • 순도&문서
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00